Differential Effects of Inflammatory and Psychosocial Stress on Mood, Hypothalamic-Pituitary-Adrenal Axis, and Inflammation in Remitted Depression

Neuropsychobiology

Volumn 74, Issue 3, 2017, Pages 150-158

  Niemegeers, Peter ^a,b   De Boer, Peter ^a,c   Dumont, Glenn J H ^a,d   Van Den Eede, Filip ^a,e   Fransen, Erik ^a   Claes, Stephan J ^f   Morrens, Manuel ^a,b,g   Sabbe, Bernard G C ^a,b,e  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Psychiatric Hospital Duffel   (Belgium)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^g Psychiatric Hospital Broeders Alexianen   (Belgium)

Author keywords

Depression; Inflammation; Psychosocial stress; Recurrent depression; Trier Social Stress Test; Typhoid vaccine; Vulnerability

Indexed keywords

CORTICOTROPIN; CYTOKINE; VACCINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DSM-IV-TR; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; INFORMED CONSENT; MAJOR DEPRESSION; MENTAL STRESS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SELF REPORT; SEX DIFFERENCE; TRIER SOCIAL STRESS TEST; VACCINATION; BLOOD; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; QUESTIONNAIRE; SINGLE BLIND PROCEDURE;

ADRENOCORTICOTROPIC HORMONE; ADULT; CROSS-OVER STUDIES; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES; VACCINES;

EID: 85018308555     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000466698     Document Type: Article

References (48)

1. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al: Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med 2013; 10:e1001547.
2. Hammen C, Kim EY, Eberhart NK, Brennan PA: Chronic and acute stress and the prediction of major depression in women. Depress Anxiety 2009; 26: 718-723.
3. Horesh N, Iancu I: A comparison of life events in patients with unipolar disorder or bipolar disorder and controls. Compr Psychiatry 2010; 51: 157-164.
4. Chrousos GP: Stress and disorders of the stress system. Nat Rev Endocrinol 2009; 5: 374-381.
5. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al: A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446-457.
6. Liu Y, Ho RC, Mak A: Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord 2012; 139: 230-239.
7. Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, et al: Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002; 26: 643-652.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Revised 4th ed. Washington, American Psychiatric Association, 1994.
9. Kendler KS, Thornton LM, Gardner CO: Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the "kindling" hypothesis. Am J Psychiatry 2000; 157: 1243-1251.
10. Monroe SM, Harkness KL: Life stress, the "kindling" hypothesis, and the recurrence of depression: considerations from a life stress perspective. Psychol Rev 2005; 112: 417-445.
11. Post RM: Mechanisms of illness progression in the recurrent affective disorders. Neurotox Res 2010; 18: 256-271.
12. Schmidt ED, Janszen AW, Wouterlood FG, Tilders FJ: Interleukin-1-induced long-lasting changes in hypothalamic corticotropinreleasing hormone (CRH) - neurons and hyperresponsiveness of the hypothalamuspituitary- adrenal axis. J Neurosci 1995; 15: 7417-7426.
13. Hayley S, Brebner K, Lacosta S, Merali Z, Anisman H: Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. J Neurosci 1999; 19: 5654-5665.
14. Johnson JD, O'Connor KA, Deak T, Spencer RL, Watkins LR, Maier SF: Prior stressor exposure primes the HPA axis. Psychoneuroendocrinology 2002; 27: 353-365.
15. Johnson JD, O'Connor KA, Deak T, Stark M, Watkins LR, Maier SF: Prior stressor exposure sensitizes LPS-induced cytokine production. Brain Behav Immun 2002; 16: 461-476.
16. Frank MG, Thompson BM, Watkins LR, Maier SF: Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses. Brain Behav Immun 2012; 26: 337-345.
17. Brydon L, Walker C, Wawrzyniak A, Whitehead D, Okamura H, Yajima J, et al: Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans. Brain Behav Immun 2009; 23: 217-224.
18. Maes M, Ombelet W, De Jongh R, Kenis G, Bosmans E: The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J Affect Disord 2001; 63: 85-92.
19. Wright CE, Strike PC, Brydon L, Steptoe A: Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav Immun 2005; 19: 345-350.
20. Strike PC, Wardle J, Steptoe A: Mild acute inflammatory stimulation induces transient negative mood. J Psychosom Res 2004; 57: 189-194.
21. Kirschbaum C, Pirke KM, Hellhammer DH: The "Trier Social Stress Test" - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993; 28: 76-81.
22. Rohleder N, Schommer NC, Hellhammer DH, Engel R, Kirschbaum C: Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom Med 2001; 63: 966-972.
23. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
24. Bernstein DP, Fink L: Childhood trauma questionnaire: a retrospective self-report. San Antonio, Pearson, 1997.
25. McNair D, Lorr M, Heuchtert J, Droppleman L: Profile of Mood States (Brief Form). North Tonawanda, Multi-Health Systems Inc., 1989.
26. Duivis HE, Vogelzangs N, Kupper N, de Jonge P, Penninx BW: Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology 2013; 38: 1573-1585.
27. Norcini Pala A, Steca P, Bagrodia R, Helpman L, Colangeli V, Viale P, et al: Subtypes of depressive symptoms and inflammatory biomarkers: an exploratory study on a sample of HIV-positive patients. Brain Behav Immun 2016; 56: 105-113.
28. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46-56.
29. Wichers MC, Koek GH, Robaeys G, Praamstra AJ, Maes M: Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive- depressive changes. Psychol Med 2005; 35: 433-441.
30. van Winkel M, Nicolson NA, Wichers M, Viechtbauer W, Myin-Germeys I, Peeters F: Daily life stress reactivity in remitted versus non-remitted depressed individuals. Eur Psychiatry 2015; 30: 441-447.
31. Pariante CM, Lightman SL: The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008; 31: 464-468.
32. Raison CL, Miller AH: When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003; 160: 1554-1565.
33. Pariante CM: Glucocorticoid receptor function in vitro in patients with major depression. Stress 2004; 7: 209-219.
34. Sorrells SF, Caso JR, Munhoz CD, Sapolsky RM: The stressed CNS: when glucocorticoids aggravate inflammation. Neuron 2009; 64: 33-39.
35. Kato TA, Hayakawa K, Monji A, Kanba S: Missing and possible link between neuroendocrine factors, neuropsychiatric disorders, and microglia. Front Integr Neurosci 2013; 7: 53.
36. Silverman MN, Pearce BD, Biron CA, Miller AH: Immune modulation of the hypothalamic- pituitary-adrenal (HPA) axis during viral infection. Viral Immunol 2005; 18: 41-78.
37. Bellavance MA, Rivest S: The HPA - immune axis and the immunomodulatory actions of glucocorticoids in the brain. Front Immunol 2014; 5: 136.
38. Van Den Eede F, Van den Bossche B, Hulstijn W, Sabbe BG, Cosyns P, Claes SJ: Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder. J Affect Disord 2006; 93: 259-263.
39. Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, et al: Major depressive disorder and hypothalamic-pituitary- adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 2009; 66: 617-626.
40. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD: Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry 2009; 66: 407-414.
41. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, et al: Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001; 58: 445-452.
42. Eisenberger NI, Inagaki TK, Rameson LT, Mashal NM, Irwin MR: An fMRI study of cytokine- induced depressed mood and social pain: the role of sex differences. Neuroimage 2009; 47: 881-890.
43. Eisenberger NI, Inagaki TK, Mashal NM, Irwin MR: Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav Immun 2010; 24: 558-563.
44. Paine NJ, Ring C, Bosch JA, Drayson MT, Veldhuijzen van Zanten JJ: The time course of the inflammatory response to the Salmonella typhi vaccination. Brain Behav Immun 2013; 30: 73-79.
45. Brydon L, Walker C, Wawrzyniak AJ, Chart H, Steptoe A: Dispositional optimism and stress-induced changes in immunity and negative mood. Brain Behav Immun 2009; 23: 810-816.
46. Coelho R, Viola TW, Walss-Bass C, Brietzke E, Grassi-Oliveira R: Childhood maltreatment and inflammatory markers: a systematic review. Acta Psychiatr Scand 2014; 129: 180-192.
47. Levine ME, Cole SW, Weir DR, Crimmins EM: Childhood and later life stressors and increased inflammatory gene expression at older ages. Soc Sci Med 2015; 130: 16-22.
48. Kenis G, Maes M: Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 2002; 5: 401-412.